# Drotaverine in Dysmenorrhoea Treatment

> **NCT00292747** · PHASE4 · TERMINATED · sponsor: **Sanofi** · enrollment: 480 (—)

## Conditions studied

- Dysmenorrhea

## Interventions

- **DRUG:** Drotaverine
- **DRUG:** Drotaverine Placebo
- **DRUG:** Ibuprofen
- **DRUG:** Ibuprofen Placebo

## Key facts

- **NCT ID:** NCT00292747
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-05-25
- **Primary completion:** 2006-02-28
- **Final completion:** 2006-02-28
- **Target enrollment:** 480 (—)
- **Why stopped:** early termination due to loss of interest and low enrollment of patient
- **Last updated:** 2017-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00292747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00292747, "Drotaverine in Dysmenorrhoea Treatment". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00292747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*